<DOC>
	<DOCNO>NCT01246583</DOCNO>
	<brief_summary>The study conduct see whether CP-690,550 ointment potential safe effective treatment adult patient mild moderate chronic plaque psoriasis .</brief_summary>
	<brief_title>CP-690-550 Ointment For Chronic Plaque Psoriasis</brief_title>
	<detailed_description />
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Tofacitinib</mesh_term>
	<criteria>Mild moderate chronic plaque psoriasis ( psoriasis vulgaris ) , duration least 6 month ; A target plaque least 9 sq . cm . Demonstrates `` rebound '' `` flare '' chronic plaque psoriasis ; Non plaque form psoriasis ; Currently history psoriatic arthritis ; Current drug induce psoriasis ; Currently systemic therapy systemic therapy psoriasis within previous 6 month ; Currently phototherapy psoriasis phototherapy within previous 3 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Multi Site</keyword>
	<keyword>Randomized</keyword>
	<keyword>Placebo Controlled</keyword>
	<keyword>Double Blind</keyword>
	<keyword>Parallel Group</keyword>
	<keyword>chronic plaque psoriasis</keyword>
	<keyword>topical treatment</keyword>
	<keyword>skin disease</keyword>
	<keyword>papulosquamous</keyword>
</DOC>